Drug Profile
Ecothiopate iodide
Alternative Names: Echothiophate iodide; Ecostigmine iodide; Ecothiopate; Ecothiophate iodide; MI-100Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Unknown
- Developer Makindus
- Class Antiglaucomas; Organothiophosphorus compounds
- Mechanism of Action Acetylcholine inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Stargardt disease
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Stargardt disease 1(New delivery system) in USA
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Stargardt disease 1 in USA
- 04 May 2015 MI 100 receives Orphan Drug status for Stargardt disease 1 in European Union